Srpski arhiv za celokupno lekarstvo 2023 Volume 151, Issue 1-2, Pages: 10-14
https://doi.org/10.2298/SARH220915011G
Full text ( 184 KB)
Comparison of Delta and Omicron variant of COVID-19 infection cases in Montenegro
Grbović Ena (Institute of Public Health of Montenegro, Podgorica, Montenegro), ena.grbovic@ijzcg.me
Galić Igor (Institute of Public Health of Montenegro, Podgorica, Montenegro)
Grbović Mensud (Vaše zdravlje Private Health Care Institution, Podgorica, Montenegro)
Madžgalj Jasmina (Secretariat for Environmental Protection, Belgrade, Serbia)
Introduction/Objective. At the end of 2021, Omicron wave (B.1.1.529) SARS-CoV-2 variant superseded the Delta variant (B.1.617). The main goal of the research is to provide a detailed and comprehensive presentation of data related to people infected with the coronavirus in Montenegro. The specific goal of the research is to determine whether virus mutations influenced the course of the epidemic during its two-year duration. Methods. This is a retrospective study. We used data from the Institute of Public Health of Montenegro. Our sample consisted of 127,134 people who tested positive for Delta or Omicron infection aged 0–100 years, who had a positive PCR test for COVID-19 between August 17, 2021 and April 17, 2022. Results. The respondents aged 40–49 years were taken as a reference group for age. The results showed that the age group from 20 to 29 years old was affected 1.03 times more than the reference group – persons belonging to the age group of 30–39 years were affected 1.07 times more than the reference group. The Central region was taken as the reference group for the region. The results showed that people who live in southern region got sick 1.14 times more often and people who live in northern region got sick 1.20 times less than people from the central region. Conclusion. The biggest predictor that a person would get sick is the age group. Also, the predictor is the region, and in our research, it was southern region.
Keywords: COVID-19, SARS-CoV-2, age, delta and omicron strain, Montenegro
Show references
Mahase E. Delta variant: What is happening with transmission, hospital admissions, and restrictions? BMJ. 2021;373:n1513. [DOI: 10.1136/bmj.n1513] [PMID: 34130949]
Bian L, Gao Q, Gao F, Wang Q, He Q, Wu X, et al. Impact of the Delta variant on vaccine efficacy and response strategies. Expert Rev Vaccines. 2021;20(10):1201-9. [DOI: 10.1080/14760584.2021.1976153] [PMID: 34488546]
Kumar S, Thambiraja TS, Karuppanan K, Subramaniam G. Omicron and Delta variant of SARS-CoV-2: A comparative computational study of spike protein. J Med Virol. 2022;94(4):1641-9. [DOI: 10.1002/jmv.27526] [PMID: 34914115]
World Health Organization. Weekly epidemiological update on COVID-19 - 28 December 2021; 2021. Available from: https://www.who.int/publications/m/item/weekly-epidemiological-update-oncovid-19---28-december-2021
Hu T, Zhang M, Deng A, Zhang Y, Li B, Li Y, et al. Comparison of Omicron and Delta Variant Infection COVID-19 Cases - Guangdong Province, China, 2022. China CDC Wkly. 2022;4(18):385-8. [DOI: 10.46234/ccdcw2022.087] [PMID: 35686204]
Kahn F, Bonander C, Moghaddassi M, Rasmussen M, Malmqvist U, Inghammar M, et al. Risk of severe COVID-19 from the Delta and Omicron variants in relation to vaccination status, sex, age and comorbidities - surveillance results from southern Sweden, July 2021 to January 2022. Euro Surveill. 2022;27(9):2200121. [DOI: 10.2807/1560-7917.ES.2022.27.9.2200121] [PMID: 35241215]
Lewnard JA, Hong VX, Patel MM, Kahn R, Lipsitch M, Tartof SY. Clinical outcomes associated with SARS-CoV-2 Omicron (B.1.1.529) variant and BA.1/BA.1.1 or BA.2 subvariant infection in Southern California. Nat Med. 2022;28(9):1933-43. [DOI: 10.1038/s41591-022-01887-z] [PMID: 35675841]
Nyberg T, Ferguson NM, Nash SG, Webster HH, Flaxman S, Andrews N, et al. Comparative analysis of the risks of hospitalization and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study. Lancet. 2022;399(10332):1303-12. [DOI: 10.1016/S0140-6736(22)00462-7] [PMID: 35305296]
Bouzid D, Visseaux B, Kassasseya C, Daoud A, Femy F, Hermand C, et al. Comparison of Patients Infected With Delta Versus Omicron COVID-19 Variants Presenting to Paris Emergency Departments: A Retrospective Cohort Study. Ann Intern Med. 2022;175(6):831-7. [DOI: 10.7326/M22-0308] [PMID: 35286147]
Bager P, Wohlfahrt J, Bhatt S, Stegger M, Legarth R, Moller CH, et al. Risk of hospitalisation associated with infection with SARS-CoV-2 omicron variant versus delta variant in Denmark: an observational cohort study. Lancet Infect Dis. 2022;22(7):967-76. [DOI: 10.1016/S1473-3099(22)00154-2] [PMID: 35468331]
Parapid B, Alasnag M, Hayes S, Samargandy S, Banerjee S, Alasnag M, et al. COVID-19 impact on women on both sides of the frontline - the American College of Cardiology Women in Cardiology Section's International Working Group perspective. Srp Arh Celok Lek. 2020;148(9-10):637-43. [DOI: 10.2298/SARH200828095P]